CSRxP Statement on 2018 Midterm Election Results
Nov 7, 2018
Out-of-control drug prices was a prominent issue on the campaign trail. With… Read More
© 2026 CSRXP- All Rights Reserved
Press & Statements
CSRxP Statement On The Trump Administration’s Proposal To Change Medicare Drug Prices
Oct 25, 2018
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
CSRxP Statement On PhRMA’s DTC Advertising Announcement
Oct 15, 2018
The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement… Read More
CSRxP Statement On HHS DTC Advertising Announcement
Oct 15, 2018
CSRxP issued the following statement in response to the U.S. Department of… Read More
Congress Rejects Big Pharma Bailout
Sep 26, 2018
Defeat For Price-Gouging Drug Manufacturers; Victory For Taxpayers &… Read More
CSRxP Urges Congress to Stop Big Pharma’s $4 Billion Bailout
Sep 25, 2018
Washington, D.C. – Today the Campaign for Sustainable Rx Pricing… Read More
CSRxP Statement on Potential Big Pharma Bailout
Sep 21, 2018
“Only Big Pharma would use bipartisan opioid legislation as another… Read More
CSRxP Statement On Exclusion Of Big Pharma Accountability Amendment In Appropriations Bill
Sep 13, 2018
House Misses Bipartisan Opportunity To Hold Big Pharma Accountable… Read More
CSRxP Urges House Members To Maintain Transparency Provision In Senate-Passed Appropriations Bill
Aug 29, 2018
CSRxP-Supported Policy Enables HHS To Require Drug Price Disclosure In… Read More
CSRxP Applauds Senate Action To Boost Drug Price Transparency For Consumers
Aug 24, 2018
Legislation Includes CSRxP-Supported Amendment Enabling HHS To Require… Read More
CSRxP Urges FDA To Finalize Guidance Critical To Lower Drug Prices
Aug 23, 2018
The Campaign for Sustainable Rx Pricing (CSRxP) today joined more than a dozen… Read More
CSRxP Applauds Trump Administration’s Focus on Out-of-Control Drug Prices
Aug 21, 2018
CSRxP spokesman Will Holley released the following statement applauding the… Read More